![]() |
Code of Federal Regulations (Last Updated: July 5, 2024) |
![]() |
Title 42 - Public Health |
![]() |
Chapter V - Office of Inspector General-Health Care, Department of Health and Human Services |
![]() |
SubChapter B - OIG Authorities |
![]() |
Part 1003 - Civil Money Penalties, Assessments and Exclusions |
![]() |
Subpart L - CMPs for Drug Price Reporting |
§ 1003.1200 - Basis for civil money penalties.
Latest version.
-
§ 1003.1200 Basis for civil money penalties.
The OIG may impose a penalty against -
(a) Any wholesaler, manufacturer, or direct seller of a covered outpatient drug that -
(1) Refuses a request for information by, or
(2) Knowingly provides false information to, the Secretary about charges or prices in connection with a survey being conducted pursuant to section 1927(b)(3)(B) of the Act; and
(b) Any manufacturer with an agreement under section 1927 of the Act that -
(1) Fails to provide any information required by section 1927(b)(3)(A) of the Act by the deadlines specified therein, or
(2) Knowingly provides any item information required by section 1927(b)(3)(A) or (B) of the Act that is false.